Unified Patent Court (UPC) analytics are now available. Check here

EP4011795

THE PROCTER & GAMBLE
Application Number
EP20213631A
Filing Date
Dec 11, 2020
Status
Granted And Under Opposition
Sep 15, 2023
Grant Date
Oct 18, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP4011795B1 was granted on Oct 18, 2023 by The Procter & Gamble The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

UNILEVER UNILEVERJul 18, 2024ADMISSIBLE
SEVINCSEVINCJul 16, 2024ADMISSIBLE
HENKELJul 4, 2024ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS2016340068
N/A
OppositionUS6296175
N/A
OppositionUS1130271
N/A
OppositionUS2711282
N/A
OppositionUS4053100
N/A
OppositionUS3692231
N/A
OppositionUS5040722
N/A
OppositionGB2358391
N/A
OppositionEP1783058
N/A
OppositionUS2018022498
N/A
OppositionUS2019135503
N/A
OppositionDE9214914U
N/A
OppositionWO2019144244
N/A
OppositionEP3907149
N/A
OppositionEP4245676
N/A
OppositionJP4536881B
N/A
OppositionUS2017355935
N/A
OppositionEP3443059
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.